An overview of current oriental medicine herbal cancer research in Korea

Jeungwon Yoon; Hwa-Seung Yoo; Yeon-Weol Lee; Chong-Kwan Cho

doi:10.1007/s11655-011-0710-6

Your Location：

Home >

Browse articles >

An overview of current oriental medicine herbal cancer research in Korea

Updated：2021-08-27

- An overview of current oriental medicine herbal cancer research in Korea
- Chinese Journal of Integrative Medicine Vol. 17, Issue 4, Pages: 251-256(2011)
- Affiliations：
  
  East-West Cancer Center, Dunsan Oriental Medical Hospital of Daejeon University, Daejeon, Republic of Korea
- Author bio：
- Funds：
  
  Supported by the “Development of Anticancer Botanical Drug through Self-Defense System Regulation Fund” of Korean Institute of Oriental Medicine;These authors contributed equally
- DOI：10.1007/s11655-011-0710-6
  CLC：
- Published：2011，
  
  Published Online：21 April 2011，
Scan for full text
Yoon, J., Yoo, HS., Lee, YW. et al. An overview of current oriental medicine herbal cancer research in Korea., Chin. J. Integr. Med. 17, 251–256 (2011). https://doi.org/10.1007/s11655-011-0710-6

Jeungwon Yoon, Hwa-Seung Yoo, Yeon-Weol Lee, et al. An overview of current oriental medicine herbal cancer research in Korea. [J]. Chinese Journal of Integrative Medicine 17(4):251-256(2011)
Yoon, J., Yoo, HS., Lee, YW. et al. An overview of current oriental medicine herbal cancer research in Korea., Chin. J. Integr. Med. 17, 251–256 (2011). https://doi.org/10.1007/s11655-011-0710-6 DOI：

Jeungwon Yoon, Hwa-Seung Yoo, Yeon-Weol Lee, et al. An overview of current oriental medicine herbal cancer research in Korea. [J]. Chinese Journal of Integrative Medicine 17(4):251-256(2011) DOI： 10.1007/s11655-011-0710-6.

摘要

Cancer is the number one cause of death in Korea with annual mortalities of 69 780. Research suggests one in every four Koreans will end up getting cancer at some point in their life time. With these persistent threats

strive for cancer cure is continued. Ten years of Korea’s oriental medicine herbal research on cancer have been reviewed. Researches between the years of 2000 and 2010 are analyzed in terms of their published year

study types

tested subjects

testing measures

cancer types

and institutions. In the past ten years

cancer researches have blossomed from null to full in Korean peninsula

and further development is much anticipated in the next ten years to come.

Abstract

study types

tested subjects

testing measures

cancer types

and institutions. In the past ten years

cancer researches have blossomed from null to full in Korean peninsula

and further development is much anticipated in the next ten years to come.

关键词

Oriental Medicineherbal researchcancerKorea

Keywords

Oriental Medicineherbal researchcancerKorea

references

Statistics Korea, 2009 leading causes of death statistics. Available from: URL: http://kostat.go.kr/portal/korea/kor_ko/5/2/index.board?bmode=read&aSeq=179513.

National Cancer Center. National cancer control programs. Retrieved 2010 Dec 29. Available from: URL: http://www.ncc.re.kr/english/programs/intro.jsp.

Shin HK, Lee NH, Lee JK, Huang DS, Kwon JW, Son KO, et al. Development plans for building infrastructure of oriental medicine in cancer treatment. Report of Korean Institute of Oriental Medicine; 2008. Report No. HB9200809231500.

Shin HK, Yoo HS. Integrative oncology toady — 11. Minjok Oriental Medicine News 2008 October 20; No. 682.

Noh EG. Annual cancer treatment costs 14 trillion won. Bogun News 2009 Jun 04. Available from: URL: http://www.bokuennews.com/news/article.html?no=34337.

Park HB. Increase in budgets for Organization Committee of Cancer Conquest 1100% and in cancer research per assignment 164%. Euiyak News 2008. Available from: URL: http://blog.naver.com/nicebongs?Redirect=Log&logNo=150035356752.

Park BK, Lee JH, Cho CK, Shin HK, Eom SK, Yoo HS. Systemic review for the clinical studies about oriental medical treatment of cancer in Korea. Korean J Orient Int Med (Korean) 2008;29:1061–1074.

PubMed. Available from: URL: http://www.ncbi.nlm.nih.gov/pubmed.

Oriental Medicine Advanced Searching Integrative System. Available from: URL: http://oasis.kiom.re.kr/portal/index.jsp.

Korean Traditional Knowledge Portal. Available from: URL: http://www.koreantk.net/en/JZ0100.jsp.

Korean Studies Information System. Available from: URL: http://search.koreanstudies.net/.

National Digital Library. Available from: URL: http://www.dlibrary.go.kr.

Research Works of East-West Cancer Center. Available from: URL: http://ewcc.or.kr/s01/s01_07_20.htm?g1=s01&dte=s01_07.

Mu Integrative Cancer Center, East-West Neo Medical Center, Kyunghee University. Research work on allergen-removed Rhus verniciflua 1996–2008. Seoul, 2008.

Crossley MJ, Turner P, Thordarson P. Clinical trials — what you need to know. Am Cancer Society 2007;129:7155.

Markman M, Cohen L, eds. Integrative oncology: incorporating complementary medicine into conventional cancer care. Totowa (NJ): Humana Press; 2008.

Yang P, Menter DG, Cartwright C, Chan D, Dixon S, Suraokar M, et al. Oleandrin-mediated inhibition of human tumor cell proliferation: importance of Na, K-ATPase alpha subunits as drug targets. Mol Cancer Ther 2009;8:2319–2328.

Lee HJ, Kim JS, Lee G, Yoon JW, Lee YW, Cho CK, et al. Toxicological study on HangAmDan-B in mice. J Acupunct Meridian Studies (Korean). In press 2011.

Lee DE, Lee SY, Kim JS, Cho CK, Yoo HS, Choi SJ. Antitumor effect of Hang-Am-Dan (HAD) and its ingredients on Calu6 and MCF-7 human cancer cell lines. J Korean Oriental Med (Korean) 2009;30(5):50–60.

Lee NH, Yoon DH, Yoo HS, Cho JH, Son CG, Lee YW, et al. Changes of serum VEGF and bFGF levels and platelet counts in 100 cancer patients treated with Hang-Am-Dan. Korean J Orient Int Med (Korean) 2005;26:753–760.

Park HM, Kim SY, Jung IC, Lee YW, Cho CK, Yoo HS. Integrative tumor board: a case report and discussion from East-West Cancer Center. Integr Cancer Ther 2010;9:236–245.

Bang JY, Kim EY, Shim TK, Yoo HS, Lee YW, Kim YS, et al. Analysis of anti-angiogenic mechanism of HangAmDan-B (HAD-B), a Korean traditional medicine, using antibody microarray chip. Bio Chip J 2010;4:350–355.

Yoo HS, Cho CK, Hong MS. Review of the best case series methodology: best case series results of East-West Cancer Center. Integr Cancer Ther 2008;7:182–188.

Eom SK, Kim KS. On estimation of indication, property and procession of Rhus Verniciflua Strokes. J Orient Med Classics (Korean) 2008;12(2):29–37.

Kim JH, Go HY, Jin DH, Kim HP, Hong MH, Chung WY, et al. Inhibition of the PI3K-Akt/PKB survival pathway enhanced an ethanol extract of Rhus Verniciflua Stokes-induced apoptosis via a mitochondrial pathway in AGS gastric cancer cell lines. Cancer Lett 2008;265:197–205.

Choi WC, Lee JH, Lee EO, Lee HJ, Yoon SW, Ahn KS, et al. Study on antiangiogenic and antitumor activities of processed Rhus Verniciflua Strokes extract. J Korean Tradit Oncol 2006;11:1229–2621.

Lee SH, Choi WC, Kim KS, Park JW, Lee SH, Yoon SW. Shrinkage of gastric cancer in an elderly patient who received Rhus Verniciflua Stokes extract. J Altern Complement Med 2010;16:497–500.

FULL TEXT LINK

More>

Views

666

Downloads

CSCD

Alert me when the article has been cited

Submit

Tools

Publicity Resources

The status of acupuncture and oriental medicine in the United States

Effectiveness of acupuncture for palliative care in cancer patients: A systematic review

Survival analysis of stage IV metastatic gastric cancer patients treated with HangAm-Plus

Reflections on the research status of Kampo Medicine: A most rewarding visit to Japan

Investigation of common symptoms of cancer and reliability analysis

Related Author

No data

Related Institution

Department of Radiation Oncology, Indiana University School of Medicine

First School of Clinical Medicine, Guangzhou University of Chinese Medicine

School of Chinese Medicine, LKS Faculty of Medicine, University of Hong Kong

East-West Cancer Center, Dunsan Oriental Hospital of Daejeon University, Soul

Center of Cardiovascular Diseases, Xiyuan Hospital, China Academy of Chinese Medical Sciences

Address：1 Caochang, xiyuan, Beijing, People's Republic of China Postal code：100091
Tel：010-62886827, 62877592 Fax：010-62874291
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备05067934号-1 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰